154 related articles for article (PubMed ID: 2501812)
41. Effects of microinjection of the D2 dopamine antagonist raclopride into the ventral tegmental area on ethanol and sucrose self-administration.
Samson HH; Chappell AM
Alcohol Clin Exp Res; 1999 Mar; 23(3):421-6. PubMed ID: 10195813
[TBL] [Abstract][Full Text] [Related]
42. Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation.
Hunt GE; Atrens DM; Jackson DM
Pharmacol Biochem Behav; 1994 Aug; 48(4):853-62. PubMed ID: 7972288
[TBL] [Abstract][Full Text] [Related]
43. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
Ogren SO; Hall H; Köhler C; Magnusson O; Sjöstrand SE
Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255
[TBL] [Abstract][Full Text] [Related]
44. The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat.
Nakajima S; Patterson RL
Brain Res; 1997 Jun; 760(1-2):74-9. PubMed ID: 9237520
[TBL] [Abstract][Full Text] [Related]
45. The hypothyroid rat as a model of increased sensitivity to dopamine receptor agonists.
Cameron DL; Crocker AD
Pharmacol Biochem Behav; 1990 Dec; 37(4):627-32. PubMed ID: 1982691
[TBL] [Abstract][Full Text] [Related]
46. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
Parashos SA; Marin C; Chase TN
Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
[TBL] [Abstract][Full Text] [Related]
47. Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.
McLaughlin PJ; Winston KM; Swezey LA; Vemuri VK; Makriyannis A; Salamone JD
Pharmacol Biochem Behav; 2010 Jul; 96(1):75-81. PubMed ID: 20403373
[TBL] [Abstract][Full Text] [Related]
48. Obese OLETF rats exhibit increased operant performance for palatable sucrose solutions and differential sensitivity to D2 receptor antagonism.
Hajnal A; Acharya NK; Grigson PS; Covasa M; Twining RC
Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1846-54. PubMed ID: 17804583
[TBL] [Abstract][Full Text] [Related]
49. Attenuation of the effects of cocaine on milk consumption in rats by dopamine antagonists.
Rapoza D; Woolverton WL
Pharmacol Biochem Behav; 1991 Sep; 40(1):133-7. PubMed ID: 1838194
[TBL] [Abstract][Full Text] [Related]
50. Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat.
Salmi P; Jimenez P; Ahlenius S
Eur J Pharmacol; 1993 Jun; 236(3):395-400. PubMed ID: 8102971
[TBL] [Abstract][Full Text] [Related]
51. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
Ogren SO; Fuxe K
Neurosci Lett; 1988 Mar; 85(3):333-8. PubMed ID: 2966309
[TBL] [Abstract][Full Text] [Related]
52. Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats.
Clifton PG; Rusk IN; Cooper SJ
Behav Neurosci; 1991 Apr; 105(2):272-81. PubMed ID: 1675060
[TBL] [Abstract][Full Text] [Related]
53. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.
Beninger RJ; Cheng M; Hahn BL; Hoffman DC; Mazurski EJ; Morency MA; Ramm P; Stewart RJ
Psychopharmacology (Berl); 1987; 92(3):343-9. PubMed ID: 2957718
[TBL] [Abstract][Full Text] [Related]
54. Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
Salmi P; Malmgren K; Svensson TH; Ahlenius S
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):593-9. PubMed ID: 9686934
[TBL] [Abstract][Full Text] [Related]
55. Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists.
Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
Psychopharmacology (Berl); 1994 Jul; 115(3):419-29. PubMed ID: 7871084
[TBL] [Abstract][Full Text] [Related]
56. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
57. Effects of dopaminergic drugs on working and reference memory in rats.
Bushnell PJ; Levin ED
Pharmacol Biochem Behav; 1993 Aug; 45(4):765-76. PubMed ID: 8105486
[TBL] [Abstract][Full Text] [Related]
58. Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc.
Steidl S; O'Sullivan S; Pilat D; Bubula N; Brown J; Vezina P
Behav Brain Res; 2017 Aug; 333():161-170. PubMed ID: 28666837
[TBL] [Abstract][Full Text] [Related]
59. The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
Millan MJ; Bervoets K; Mavridis M
Neurosci Lett; 1991 Sep; 130(2):173-6. PubMed ID: 1795876
[TBL] [Abstract][Full Text] [Related]
60. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
